Literature DB >> 24252836

Into the wild world of eosinophilic granuloma.

Anil Kumar Dhull1, Sumeet Aggarwal, Vivek Kaushal, Sunita Singh.   

Abstract

Langerhans cell histiocytosis (LCH) is a group of relatively rare disease processes of reticuloendothelial system with an abnormal proliferation of Langerhans cells or their precursors. A wide spectrum of treatment modalities is available for LCH which includes surgery, curettage, steroids, radiation, various chemotherapy regimens, either in combination or alone have so far been adopted. There are several case reports of eosinophilic granuloma but for recurrent cases very few have discussed on treatment of LCH in adults. We report a case of a 21-year-old man presented with eosinophilic granuloma with recurrence of the lesions after 6 years of the initial treatment. Patient was treated with combination chemotherapy with three weekly CHOP regimen and the patient is disease free after 6 months of follow-up. Contrary to other reports, this case demonstrates that a good response with standard therapy is possible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24252836      PMCID: PMC3841435          DOI: 10.1136/bcr-2013-200522

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations.

Authors:  Cristina Madrigal-Martínez-Pereda; Vanesa Guerrero-Rodríguez; Blanca Guisado-Moya; Cristina Meniz-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2009-05-01

2.  Primary langerhans cell histiocytosis of the vulva: report of a case and brief review of the literature.

Authors:  Zenggang Pan; Sanjeev Sharma; Poonam Sharma
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

3.  Polyostotic eosinophilic granuloma of the jaws treated by chemotherapy. A case report.

Authors:  A C Abrahão; M G Cabral; C W Noce Dos Santos; M E R Janini; W A Pulcheri
Journal:  Minerva Stomatol       Date:  2007 Jul-Aug

4.  [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].

Authors:  Z Adam; P Szturz; J Duraš; L Pour; M Krejčí; Z Rehák; R Koukalová; M Navrátil; R Hájek; Z Král; J Mayer
Journal:  Klin Onkol       Date:  2012

5.  Optimal therapy for adults with Langerhans cell histiocytosis bone lesions.

Authors:  Maria A Cantu; Philip J Lupo; Mrinalini Bilgi; M John Hicks; Carl E Allen; Kenneth L McClain
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.